Alnylam Pharmaceuticals, Inc. (ALNY) Earnings
NASDAQ·Healthcare·Biotechnology
$217.51
-1.28%
Mkt Cap $27.50B
EPS — Estimate vs Actual
Mkt Cap
$27.50B
P/E
52.00
Fwd P/E
30.39
P/S
6.41
Rev TTM
—
EPS TTM
$4.21
NASDAQ·Healthcare·Biotechnology
$217.51
-1.28%
Mkt Cap $27.50B
Mkt Cap
$27.50B
P/E
52.00
Fwd P/E
30.39
P/S
6.41
Rev TTM
—
EPS TTM
$4.21